Moreno Gijón María, Suárez Sánchez Aida, de Santiago Álvarez Irene, Rodicio Miravalles Jose Luis, Amoza Pais Sonia, Rodríguez Uría Raquel, Sanz Navarro Sandra, Díaz Vico Tamara, Turienzo Santos Estrella, Sanz Álvarez Lourdes
General Surgery Department, Asturias Central University Hospital (HUCA), Oviedo, Spain; Health Research Institute of the Principality of Asturias (ISPA), Oviedo, Spain.
General Surgery Department, Asturias Central University Hospital (HUCA), Oviedo, Spain; Health Research Institute of the Principality of Asturias (ISPA), Oviedo, Spain. Electronic address: https://www.twitter.com/AidukiSuarez.
Surgery. 2025 Feb;178:108920. doi: 10.1016/j.surg.2024.10.011. Epub 2024 Nov 29.
The secondary consequences of surgical site occurrences, especially surgical site infections, worsen the patient's outcomes while significantly increasing health care costs. The implementation of preventive measures to reduce this complication rate should be one of the priorities to improve health care.
A randomized, open-label clinical trial was conducted between March 2019 and March 2021 in a general surgery department. Individuals who had undergone laparotomy and had risk factors for developing surgical site infections and surgical site occurrences were included and randomized to use either negative-pressure wound therapy or conventional dressing (control group) on the closed surgical incision. The aim of our study was to evaluate the benefit of negative-pressure wound therapy in the surgical site infection rates and other surgical site occurrences in both groups at a 30-day follow-up.
Two hundred seventy-five participants were recruited and were analyzed, 147 (53.5%) in the negative-pressure wound therapy group and 128 (46.5%) in the control group. Thirty-one (11.3%) surgical site infections and 71 (25.8%) other surgical site occurrences were observed, being significantly lower in the negative-pressure wound therapy group (odds ratio 0.31, 95% confidence interval 0.14-0.71; P = .005) and (odds ratio 0.51, 95% confidence interval 0.29-0.90; P = .02), respectively. Absolute risk reduction was 13% for surgical site infection and 12% for other surgical site occurrences. Number needed to treat 9 (95% confidence interval 5-29) for surgical site infection and number needed to treat of 8 (95% confidence interval 5-51) for other surgical site occurrences. Median hospital stay was 3 days lower in the negative-pressure wound therapy group than in the control group (9 vs 12 days; P = .03). No severe adverse events attributable to the negative-pressure wound therapy dressing were reported.
Negative-pressure wound therapy decreases the risk of surgical site occurrences and surgical site infection after laparotomy, so that its use should be considered in patients with risk factors.
手术部位事件的继发后果,尤其是手术部位感染,会使患者的预后恶化,同时显著增加医疗成本。实施预防措施以降低这种并发症发生率应是改善医疗保健的优先事项之一。
2019年3月至2021年3月在普通外科进行了一项随机、开放标签的临床试验。纳入接受剖腹手术且有发生手术部位感染和手术部位事件风险因素的个体,并随机分为在闭合手术切口上使用负压伤口治疗或传统敷料(对照组)。我们研究的目的是在30天随访时评估负压伤口治疗对两组手术部位感染率和其他手术部位事件的益处。
招募并分析了275名参与者,负压伤口治疗组147名(53.5%),对照组128名(46.5%)。观察到31例(11.3%)手术部位感染和71例(25.8%)其他手术部位事件,负压伤口治疗组显著更低(比值比0.31,95%置信区间0.14 - 0.71;P = 0.005)和(比值比0.51,95%置信区间0.29 - 0.90;P = 0.02)。手术部位感染的绝对风险降低为13%,其他手术部位事件为12%。手术部位感染的需治疗人数为9(95%置信区间5 - 29),其他手术部位事件的需治疗人数为8(95%置信区间5 - 51)。负压伤口治疗组的中位住院时间比对照组短3天(9天对12天;P = 0.03)。未报告归因于负压伤口治疗敷料的严重不良事件。
负压伤口治疗可降低剖腹手术后手术部位事件和手术部位感染的风险,因此对于有风险因素的患者应考虑使用。